New-Onset Diabetes in Covid-19
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
There is a bidirectional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with an increased risk of severe Covid-19. On the other hand, new-onset diabetes and severe metabolic complications of preexisting diabetes, including diabetic ketoacidosis and hyperosmolarity for which exceptionally high doses of insulin are warranted, have been observed in patients with Covid-19. These manifestations of diabetes pose challenges in clinical management and suggest a complex pathophysiology of Covid-19–related diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
COVID ‐19 infection may cause ketosis and ketoacidosis
Li, J., Wang, X., Chen, J., Zuo, X., Zhang, H., & Deng, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14057 · Cited by 455
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus
Chee, Y. J., Ng, S. J. H., & Yeoh, E. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108166 · Cited by 287
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
Ren, H., Yang, Y., Wang, F., Yan, Y., Shi, X., Dong, K., Yu, X., & Zhang, S. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01035-2 · Cited by 200
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Human Wound and Its Burden: Updated 2020 Compendium of Estimates
Sen, C. K. (2021) · Advances in Wound Care · doi:10.1089/wound.2021.0026 · Cited by 1,017
Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
Ayoubkhani, D., Khunti, K., Nafilyan, V., Maddox, T., Humberstone, B., Diamond, I., & Banerjee, A. (2021) · BMJ · doi:10.1136/bmj.n693 · Cited by 832
Self-citationThe Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Pathological sequelae of long-haul COVID
Mehandru, S., & Merad, M. (2022) · Nature Immunology · doi:10.1038/s41590-021-01104-y · Cited by 657
Metadata
- Authors
- Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., Del Prato, S., Ji, L., Hopkins, D., Herman, W. H., Khunti, K., Mbanya, J.-C., & Renard, E.
- Affiliations
- King's College London (GB)
- Monash University (AU)
- Imperial College London (GB)
- Technische Universität Dresden (DE)
- University of Colorado Anschutz (US)
- Agostino Gemelli University Polyclinic (IT)
- Nanyang Technological University (SG)
- University of Pisa, Pisa, Italy
- Peking University (CN)
- Kings Health Partners (GB)
- University of Michigan (US)
- University of Leicester (GB)
- Université de Yaoundé I (CM)
- University of Montpellier, Montpellier, France
- Corresponding author
- Rubino, Francesco
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-08-20
- Volume
- 383
- Issue
- 8
- Pages
- 789-790
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC7304415
- OpenAlex
- W3035586023
- Cited by
- 801
- References
- 5
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 58 · 2023: 112 · 2022: 199 · 2021: 258 · 2020: 124
- FWCI
- 22.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- HAL (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Transcampus of Technische Universität Dresden & King’s College London
- King’s College London, London, UK and Monash University, Melbourne Australia
- Institute of Diabetes, Endocrinology, Obesity, King’s Health Partners
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- new-onset diabetes, COVID-19 pandemic, diabetic ketoacidosis, hyperosmolar hyperglycemic state, severe COVID-19, insulin therapy
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Diabetes Mellitus, Glucose, Humans, Pneumonia, Viral, Registries, Global Health, Coronavirus Infections, Diabetes Complications, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New-Onset Diabetes in Covid-19. https://app.cochat.ai/papers/10.1056/nejmc2018688
- The paper
- Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., Del Prato, S., Ji, L., Hopkins, D., Herman, W. H., Khunti, K., Mbanya, J.-C., & Renard, E. (2020). New-Onset Diabetes in Covid-19. New England Journal of Medicine. https://doi.org/10.1056/nejmc2018688
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.